Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Provid Pharmaceuticals Inc.
DescriptionSmall molecule peptide mimetic
Molecular Target Major histocompatibility complex class II DR2 (HLA-DR2)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today